Where NewAmsterdam Pharma Stands With Analysts - Nasdaq

Where NewAmsterdam Pharma Stands With Analysts - Nasdaq

3 weeks from now

Dec 30, 2024  · In the assessment of 12-month price targets, analysts unveil insights for NewAmsterdam Pharma, presenting an average target of $39.83, a high estimate of $48.00, …

nasdaq.com

NewAmsterdam Pharma Stock: A Deep Dive Into Analyst ... - Nasdaq

3 weeks from now

Nov 11, 2024  · Return on Assets (ROA): NewAmsterdam Pharma's ROA stands out, surpassing industry averages. With an impressive ROA of -3.76%, the company demonstrates effective …

nasdaq.com

NewAmsterdam Pharma (NAMS) Stock Forecast & Price Target

3 weeks from now

4 days ago  · According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for NewAmsterdam Pharma is $41.60, with a high …

marketbeat.com

NewAmsterdam Pharma (NASDAQ:NAMS) Stock, Analyst Ratings …

3 weeks from now

Jan 1, 2019  · NewAmsterdam Pharma Co NV has a consensus price target of $32.67 based on the ratings of 11 analysts. The high is $48 issued by HC Wainwright & Co. on January 14, …

benzinga.com

NewAmsterdam Pharma Company N.V. (NAMS) - Zacks …

3 weeks from now

6 days ago  · Based on short-term price targets offered by eight analysts, the average price target for NewAmsterdam Pharma Company N.V. comes to $42.63. The forecasts range from a low …

zacks.com

NewAmsterdam Pharma (NASDAQ:NAMS) Now Covered By …

3 weeks from now

Dec 30, 2024  · A number of other equities research analysts also recently weighed in on the stock. Scotiabank lifted their price target on shares of NewAmsterdam Pharma from $35.00 to …

marketbeat.com

RBC Capital Sticks To Their Buy Rating For NewAmsterdam Pharma …

3 weeks from now

6 days ago  · NewAmsterdam Pharma Company has an analyst consensus of Strong Buy, with a price target consensus of $43.83. See the top stocks recommended by analysts >> The …

businessinsider.com

NewAmsterdam Pharma's Cholesterol Drug To See Blockbuster …

3 weeks from now

Aug 28, 2024  · Also Read: Analyst Confident In NewAmsterdam Pharma’s Cholesterol Drug Despite Mixed Reactions To Study Results. Obicetrapib lowered LDL-C by 36.3% on day 84 …

benzinga.com

Expert Ratings For NewAmsterdam Pharma - Nasdaq

3 weeks from now

Sep 23, 2024  · Analysts have set 12-month price targets for NewAmsterdam Pharma, revealing an average target of $33.75, a high estimate of $37.00, and a low estimate of $31.00.

nasdaq.com

NewAmsterdam Pharma (NASDAQ:NAMS) Trading Up 4.1

3 weeks from now

2 days ago  · Analyst Ratings Changes. A number of brokerages have issued reports on NAMS. Scotiabank boosted their price target on NewAmsterdam Pharma from $35.00 to $47.00 and …

marketbeat.com